Fully two years into the COVID-19 pandemic, biopharmaceutical companies and academic/non-profit research organizations continue to partner on efforts to prevent and combat infections by the SARS-CoV-2 virus. But while the pandemic remains ongoing, a coalition of translational research bodies is using learnings from the COVID-19 experience to propose actions to help with the next pandemic.
Translation Together, an alliance comprising seven translational research organizations across North America, South America, the UK, European Union and Asia-Pacific, published an article on 28 January in Nature Reviews/Drug Discovery recommending five ways to better facilitate translational
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?